Request availability and a quotation for your required quantity and destination.
| Product | Semaglutide 0.25 mg / 0.5 mg - Generic Ozempic Alternative Pen |
|---|---|
| Categories | Weight Loss |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Composition and product identification: Listed semaglutide injection pen with 0.25 mg and 0.5 mg doses. Brand identity, pen design, concentration, manufacturer and approval status must be checked.
Semaglutide is a GLP-1 receptor agonist prescribed in certain approved products for type 2 diabetes or weight management. Device and labeled indications vary. Do not assume a purported generic or alternative is interchangeable with an approved Ozempic pen.
Gastrointestinal symptoms and dehydration may occur. Product labels include important warnings and contraindications, including risk of pancreatitis or gallbladder problems and restrictions relating to medullary thyroid carcinoma or MEN2 in some jurisdictions. Clinicians must verify the exact product and injection instructions.
Semaglutide versus tirzepatide guide. Verify that related information applies to this exact formulation; links do not establish product approval.
Any enquiry requires confirmation of the actual ingredients, manufacturer, approval status, prescription or veterinary authorization and destination-country import regulations. This description is educational and has not been independently medically reviewed.